Dose forms comprising VX-950 and their dosage regimen

Details for Australian Patent Application No. 2005302361 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors McNair, Lindsay; Chu, Hui-May; Alam, John; Ette, Ene

Agent Cullens

Pub. Number AU-B-2005302361

PCT Pub. Number WO2006/050250

Priority 60/722,746 30.09.05 US; 60/623,542 29.10.04 US; 60/679,402 09.05.05 US; 60/682,091 17.05.05 US

Filing date 31 October 2005

Wipo publication date 11 May 2006

Acceptance publication date 17 November 2011

International Classifications

A61K 31/454 (2006.01)

A61K 31/7056 (2006.01)

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

31 May 2007 PCT application entered the National Phase

  PCT publication WO2006/050250 Priority application(s): WO2006/050250

17 November 2011 Application Accepted

  Published as AU-B-2005302361

15 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005302372-Valves for fuel cartridges

2005302351-Heterocyclical anti-aromatic chromophore architectures